Showing 2401-2410 of 2494 results for "".
- Eyevensys Presents Initial Data from Phase 1/2 Trial of Non-Viral Gene Therapy for Ocular Diseaseshttps://modernod.com/news/eyevensys-presents-initial-data-from-phase-1-2-trial-of-non-viral-gene-therapy-for-ocular-diseases/2476987/Eyevensys this week presented results from part 1 of its phase 1/2 study for noninfectious uveitis (NIU) at the Ophthalmology Innovation Summit’s (OIS) 11th Annual OIS@AAO conference on October 10, 2019 in San Francisco. Ronald R. Buggage, MD, Chief Medical Officer of Eyevensys, discussed the nov
- World’s Leading Eye Physicians and Surgeons Gather in San Francisco to Inspire the Future of Eye Carehttps://modernod.com/news/worlds-leading-eye-physicians-and-surgeons-gather-in-san-francisco-to-inspire-the-future-of-eye-care/2476986/More than 25,000 are expected to attend the American Academy of Ophthalmology’s 123rd annual meeting, AAO 2019, from Oct. 12-15 at the Moscone Center in San Francisco. The 4-day meeting offers opportunities to hear from the greatest minds in medical and surgical eye care discuss the la
- Alcon Celebrates World Sight Day, Strengthens Commitment to Enhancing Global Access to Eye Carehttps://modernod.com/news/alcon-celebrates-world-sight-day-strengthens-commitment-to-enhancing-global-access-to-eye-care/2476983/Thousands of Alcon associates worldwide are participating in activities to support the advancement of eye health in honor of World Sight Day. To celebrate the occasion, the company announced a theme for the upcoming year, “Alcon: The Official Sponsor of 20/20,” which is designed to highlight its
- Mynosys Secures $25 Million Investment; Names Rob Thornhill as CEOhttps://modernod.com/news/mynosys-secures-25-million-investment-names-rob-thornhill-as-ceo/2476976/Mynosys Cellular Devices, manufacturer of the Zepto cataract surgery device, announced it finalized a $25 million financing round, led by Decheng Capital, and named veteran ophthalmology industry executive Rob Thornhill as Chief Executive Officer. This financing provides capital to fuel U.
- Modernizing Medicine to Display Integrated Ophthalmology Software Suite at AAOhttps://modernod.com/news/modernizing-medicine-to-display-integrated-ophthalmology-software-suite-at-aao/2476967/Modernizing Medicine will showcase the latest advancements to its suite of products, modmed Ophthalmology, as well as general availability for a new product offering, modmed ASC, at the American Academy of Ophthalmology Annual Meeting (AAO) in San Francisco. Attendees will have the opportunity to
- Novartis Receives FDA Approval for Beovu for Wet AMDhttps://modernod.com/news/novartis-receives-fda-approval-for-beovu-for-wet-amd/2476953/Novartis announced that the FDA approved Beovu (brolucizumab-dbll) injection, also known as RTH258, for the treatment of wet age-related macular degeneration (AMD). Beovu is the first FDA approved anti-VEGF to offer both greater fluid resolution versus aflibercept and the ability to maintain elig
- Vision 2020 USA to Hold Annual World Sight Day Briefing on October 17, 2019https://modernod.com/news/vision-2020-usa-to-hold-annual-world-sight-day-briefing-on-october-17-2019/2476939/As part of World Sight Day events, on Oct. 17, 2019, Vision 2020 USA will be holding an educational luncheon briefing at the Rayburn House Office Building, 2075, in aWashington DC, from noon to 1 p.m. According to Prevent Blindness, by 2050, the impaired and blind populations are projecte
- Compulink Launches E-Commerce Solution for its All-in-One Optometry EHR at Vision Expo Westhttps://modernod.com/news/compulink-launches-e-commerce-solution-for-its-all-in-one-optometry-ehr-at-vision-expo-west/2476895/Compulink Healthcare Solutions will officially unveil its MyEyeStore e-commerce solution at Vision Expo West from September 19-21, 2019 in Las Vegas. MyEyeStore allows eye care practices to offer their patients the ability to order contact lenses and other recommended products directly fro
- Oyster Point Pharma Expands Executive Leadership Teamhttps://modernod.com/news/oyster-point-pharma-expands-executive-leadership-team/2476896/Oyster Point Pharma announced the appointment of Dan Lochner, MBA, as its Chief Financial Officer, and John Snisarenko, MBA, as Chief Commercial Officer. Mr. Lochner joins Oyster Point Pharma after spending nearly 15 years, most recently as a Managing Director, at Goldman Sachs asset mana
- RightEye Releases Fully Commercialized Version of EyeQ Trainer Oculomotor Exercise Programhttps://modernod.com/news/righteye-releases-fully-commercialized-version-of-eyeq-trainer-oculomotor-exercise-program/2476892/RightEye has released its fully commercialized version of EyeQ Trainer, an oculomotor exercise program. Paired with its suite of EyeQ Tests, RightEye now offers a complete solution for addressing functional vision impairments faced by millions of Americans. The product will showcase at Vis